Restriction Enzymes HindIII

A restriction enzyme or restriction endonuclease is defined as a protein that recognizes a specific, short nucleotide sequence and cuts the DNA only at or near that site, known as restriction site or target sequence. The four most common types of restriction enzymes include: Type I (cleaves at sites remote from a recognition site), Type II (cleaves within or at short specific distances from a recognition site), Type III (cleave at sites a short distance from a recognition site), and Type IV (targets modified DNA- methylated, hydroxymethylated and glucosyl-hydroxymethylated DNA). The most common challenges with restriction digest include- 1. inactivation of the enzyme, 2. incomplete or no digestion, and 3. unexpected cleavage. The enzyme should always be stored at -20C and multiple freeze-thaw cycles should be avoided in order to maintain optimal activity. Always use a control DNA digestion with the enzyme to ensure adequate activity (to avoid interference due to high glycerol in the enzyme). For complete digestion, make sure that the enzyme volume is 1/10th of the total reaction volume, the optimal temperature is constantly maintained throughout the reaction, the total reaction time is appropriately calculated based on the amount of DNA to be digested, appropriate buffers should be used to ensure maximal enzymatic activity, and in case of a double digest, make sure that the two restriction sites are far enough so that the activity of one enzyme cannot interfere with the activity of the other. Star activity (or off-target cleavage) and incomplete cleavage are potential challenges which may occur due to suboptimal enzymatic conditions or inappropriate enzyme storage. To avoid these, follow the recommended guidelines for storage and reactions, and always check for the efficacy of digestion along with purification of digested products on an agarose gel.

Start discussion

No discussions found

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Found 5 matching solutions for this experiment

FastDigest HindIII

Thermo Fisher Scientific

Protocol tips
Digestion reactions were set up in 12 μl volume using 96 fmoles of duplex per reaction, with SUPERase•In™ RNase Inhibitor 1 U/μl, in the buffer recommended by the manufacturer. Enzymes were used at a maximum concentration compatible with glycerol content lower than 4.75%. MvaI, HindIII, PvuII (Fastdigest™ series) and BcnI enzymes were from Thermo Scientific™. AvaII, HinP1I and EcoRV were from New England Biolabs.
Protocol tips
The clone 4G4E4.0 encompassing a 4-kb EcoRI 59 fragment of the human huntingtin gene (including exon 1 and upstream noncoding region) (Lin et al.,
1995) was characterized by restriction endonuclease mapping with EcoRI, HindIII, and SfiI. A region of 3345 nt of the 59-untranslated region was deleted by double digestion with HindIII and SfiI to form a human huntingtin exon 1 transcription plasmid (clone 839; Fig. 1).
HindIII-HF®

New England BioLabs

Protocol tips
The plasmid DNA of pBS3ndd was isolated using the alkaline lysis method, then linearized by digestion with EcoRI-HF and HindIII-HF for 3 h. Cut vector was precipitated with two volumes of absolute ethanol, incubated at −80 °C for 1 h, and then harvested by centrifugation at 16,000×g at room temperature for 10 min. The DNA pellet was rinsed once with 70% ethanol, air-dried, and resuspended with TE buffer.
HindIII NEB #R0104

New England BioLabs

Protocol tips
The DNA fragments of the PCR were purified with the QIAquick PCR purification kit (Qiagen, Inc., Valencia, CA) and afterward digested with HindIII and BamHI (New England Biolabs, Beverly, MA).
Protocol tips
After digested with BamHI and HindIII (Takara), the PCR products were cloned into expression vector, pET-32a(+) (Novagen).
Can't find the product you've used to perform this experiment? It would be great if you can help us by Adding a product!

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms